Cargando…
Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
The cellular prion protein PrP(C) mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP(C) (GDL) can also initiate neurotoxicity by inducing an intramolecular R(208)‐H(140) hydrogen bond (“H...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041163/ https://www.ncbi.nlm.nih.gov/pubmed/36329611 http://dx.doi.org/10.1111/bpa.13130 |
_version_ | 1784912648122400768 |
---|---|
author | Reimann, Regina R. Puzio, Martina Rosati, Antonella Emmenegger, Marc Schneider, Bernard L. Valdés, Pamela Huang, Danzhi Caflisch, Amedeo Aguzzi, Adriano |
author_facet | Reimann, Regina R. Puzio, Martina Rosati, Antonella Emmenegger, Marc Schneider, Bernard L. Valdés, Pamela Huang, Danzhi Caflisch, Amedeo Aguzzi, Adriano |
author_sort | Reimann, Regina R. |
collection | PubMed |
description | The cellular prion protein PrP(C) mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP(C) (GDL) can also initiate neurotoxicity by inducing an intramolecular R(208)‐H(140) hydrogen bond (“H‐latch”) between the α2‐α3 and β2‐α2 loops of PrP(C). Importantly, GDL that suppresses the H‐latch prolong the life of prion‐infected mice, suggesting that GDL toxicity and prion infections exploit convergent pathways. To define the structural underpinnings of these phenomena, we transduced 19 individual PrP(C) variants to PrP(C)‐deficient cerebellar organotypic cultured slices using adenovirus‐associated viral vectors (AAV). We report that GDL toxicity requires a single N‐proximal cationic residue (K(27) or R(27)) within PrP(C). Alanine substitution of K(27) also prevented the toxicity of PrP(C) mutants that induce Shmerling syndrome, a neurodegenerative disease that is suppressed by co‐expression of wild‐type PrP(C). K(27) may represent an actionable target for compounds aimed at preventing prion‐related neurodegeneration. |
format | Online Article Text |
id | pubmed-10041163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100411632023-03-28 Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity Reimann, Regina R. Puzio, Martina Rosati, Antonella Emmenegger, Marc Schneider, Bernard L. Valdés, Pamela Huang, Danzhi Caflisch, Amedeo Aguzzi, Adriano Brain Pathol Research Articles The cellular prion protein PrP(C) mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP(C) (GDL) can also initiate neurotoxicity by inducing an intramolecular R(208)‐H(140) hydrogen bond (“H‐latch”) between the α2‐α3 and β2‐α2 loops of PrP(C). Importantly, GDL that suppresses the H‐latch prolong the life of prion‐infected mice, suggesting that GDL toxicity and prion infections exploit convergent pathways. To define the structural underpinnings of these phenomena, we transduced 19 individual PrP(C) variants to PrP(C)‐deficient cerebellar organotypic cultured slices using adenovirus‐associated viral vectors (AAV). We report that GDL toxicity requires a single N‐proximal cationic residue (K(27) or R(27)) within PrP(C). Alanine substitution of K(27) also prevented the toxicity of PrP(C) mutants that induce Shmerling syndrome, a neurodegenerative disease that is suppressed by co‐expression of wild‐type PrP(C). K(27) may represent an actionable target for compounds aimed at preventing prion‐related neurodegeneration. John Wiley and Sons Inc. 2022-11-03 /pmc/articles/PMC10041163/ /pubmed/36329611 http://dx.doi.org/10.1111/bpa.13130 Text en © 2022 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Reimann, Regina R. Puzio, Martina Rosati, Antonella Emmenegger, Marc Schneider, Bernard L. Valdés, Pamela Huang, Danzhi Caflisch, Amedeo Aguzzi, Adriano Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity |
title | Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity |
title_full | Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity |
title_fullStr | Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity |
title_full_unstemmed | Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity |
title_short | Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity |
title_sort | rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041163/ https://www.ncbi.nlm.nih.gov/pubmed/36329611 http://dx.doi.org/10.1111/bpa.13130 |
work_keys_str_mv | AT reimannreginar rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT puziomartina rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT rosatiantonella rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT emmeneggermarc rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT schneiderbernardl rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT valdespamela rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT huangdanzhi rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT caflischamedeo rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity AT aguzziadriano rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity |